Filing Details
- Accession Number:
- 0000915913-20-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-17 07:47:20
- Reporting Period:
- 2020-01-15
- Accepted Time:
- 2020-01-17 07:47:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
915913 | Albemarle Corp | ALB | Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) | 541692118 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1511133 | Scott Tozier | Albemarle Corporation 4250 Congress Street, Suite 900 Charlotte NC 28209 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-01-15 | 14,500 | $66.14 | 66,925 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-01-15 | 14,500 | $80.13 | 52,425 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option | Disposition | 2020-01-15 | 14,500 | $0.00 | 14,500 | $66.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,591 | Indirect | Albemarle Savings Plan |
Footnotes
- Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan (the "Albemarle Savings Plan") as of the date of this Form 4.
- The option exercise and share sale reported in this Form 4 was effected pursuant to a previously adopted and approved Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.005 to $80.48, inclusive. The Reporting Person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Stock Option vested in three equal installments over 3 years: 2/24/2013, 2/24/2014, and 2/24/2015.